8-Chlorotheophylline, also known as 1,3-dimethyl-8-chloroxanthine, is a stimulant drug of the xanthine chemical class, with physiological effects similar to caffeine. Its main use is in combination (salt) with diphenhydramine in the antiemetic dimenhydrinate (Dramamine). Diphenhydramine reduces nausea but causes drowsiness, and the stimulant properties of 8-Chlorotheophylline help reduce that side effect.
Despite being classified as a xanthine stimulant, 8-chlorotheophylline generally does not produce any hyperlocomotion above control in mice and does not appear to cross the blood-brain barrier well.
The 8-chloro modification is not selected for pharmacological properties; instead, it was to raise the acidity of the xanthine amine group enough to form a co-salt with diphenhydramine.
The drug is also sold in combination with promethazine as a salt.
Safety at a Glance
High Risk- General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual se...
- Toxicity: 8-Chlorotheophylline carries significant toxicity risks, particularly with chronic use or high doses. Stimulant toxic...
- Dangerous with: Atropa belladonna, Datura, Diphenhydramine, Harmala alkaloid (+3 more)
- Overdose risk: Stimulant overdose from 8-Chlorotheophylline is a medical emergency primarily involving cardiovas...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
oral
Duration
oral
Total: 3 hrs – 5 hrsHow It Feels
8-Chlorotheophylline announces itself with the quiet, unassuming character of a compound that barely qualifies as psychoactive. Within thirty to sixty minutes of oral ingestion, there is a mild brightening of attention, as though the mind has been gently nudged from a state of rest toward one of activity. Fatigue recedes incrementally. The eyes focus with slightly less effort. There is a suggestion of increased alertness that is real but modest, hovering at the boundary between a pharmacological effect and the ordinary fluctuation of wakefulness that occurs throughout any given day.
At its subtle peak, the experience is dominated by a gentle, xanthine-class stimulation. It is less potent than caffeine and considerably less interesting. There is no euphoria, no increased sociability, no enhanced sensory perception. Instead, there is simply a mild reduction in drowsiness and a slight improvement in the ability to sustain attention. The mind does not race or sharpen; it merely becomes marginally less likely to drift. Coffee drinkers will find the effect familiar but diminished, like hearing a favorite song played at half volume through a wall.
Physically, the effects are barely detectable. Heart rate may increase by a few beats per minute. There may be a very slight bronchodilation, an easing of breathing so subtle that it would only be noticed by someone already experiencing mild respiratory congestion. Appetite is unaffected. There is no jaw tension, no sweating, no vasoconstriction. The body proceeds through its day largely unaware that anything unusual has been consumed.
The effects taper over three to five hours, dissolving back into baseline without ceremony. There is no comedown, no rebound fatigue, no sleep disruption. The substance's primary significance lies not in its own psychoactive effects, which are negligible, but in its role as a component of other formulations, most notably dimenhydrinate, where it serves as a mild stimulant counterbalance to the sedation of diphenhydramine. On its own, 8-chlorotheophylline is a footnote in pharmacology, a compound that illustrates through its very mildness how narrow the gap can be between psychoactively active and pharmacologically inert.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(11)
- Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
- Bronchodilation— Bronchodilation is the widening of the bronchial airways in the lungs, reducing resistance to airflo...
- Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
- Frequent urination— Increased urinary frequency beyond normal patterns, caused by diuretic effects or bladder irritation...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Muscle tension— Persistent partial contractions or tightening of muscles that produces uncomfortable stiffness, cram...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
- Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
- Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...
Cognitive & Perceptual Effects
Cognitive(9)
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Compulsive redosing— An overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maint...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Empathy enhancement— A state of intensified compassion and emotional openness in which one feels deeply connected to othe...
- Irritability— Irritability is a sustained state of emotional reactivity in which the threshold for annoyance, frus...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Pharmacology
8-Chlorotheophylline increases monoaminergic neurotransmission through one or more mechanisms: reuptake inhibition at dopamine (DAT), norepinephrine (NET), and/or serotonin (SERT) transporters; direct release of monoamines through transporter reversal; or inhibition of monoamine oxidase (MAO) enzymes. The specific mechanism and relative selectivity for different monoamine systems determines the compound's subjective profile.
The dopaminergic effects, particularly in the mesolimbic reward pathway (ventral tegmental area to nucleus accumbens), are primarily responsible for the euphoria and reinforcing properties. Noradrenergic stimulation mediates many of the peripheral sympathomimetic effects including increased heart rate, blood pressure, and alertness. Serotonergic activity, when present, contributes to mood elevation and, at higher levels, empathogenic qualities.
Repeated exposure can lead to neuroadaptive changes including downregulation of dopamine receptors, reduced dopamine synthesis capacity, and altered transporter expression, which underlie tolerance and withdrawal phenomena.
Detection Methods
Standard Drug Panel Inclusion
8-Chlorotheophylline is a chlorinated xanthine derivative (related to caffeine and theophylline) that is not detected on any standard drug panel. Xanthines are not controlled substances and are not targeted by any workplace, clinical, or forensic drug test. 8-Chlorotheophylline is primarily encountered as a component of dimenhydrinate (Dramamine), where it is combined with diphenhydramine.
Urine Detection
8-Chlorotheophylline is excreted in urine over approximately 12 to 24 hours. It undergoes hepatic demethylation and oxidation, producing metabolites similar to those of theophylline. No standard or extended drug screen targets xanthine derivatives. Detection is only relevant in clinical pharmacokinetic studies or forensic investigations where dimenhydrinate intake is in question.
Blood and Saliva Detection
Blood concentrations of 8-chlorotheophylline decline with a half-life of approximately 3 to 6 hours. Detection in blood is straightforward with standard clinical chemistry assays for theophylline (with modification for the chlorine substituent), but this is rarely clinically indicated. Saliva testing is not used.
Hair Follicle Detection
Hair testing for 8-chlorotheophylline is not performed by any commercial laboratory. The compound has no relevance to drug monitoring or forensic testing programs.
Confirmatory Testing
LC-MS/MS and GC-MS can identify 8-chlorotheophylline based on its molecular weight and chlorine isotope pattern. However, this analysis is virtually never requested outside of research contexts.
Reagent Testing
Standard reagent tests are not applicable to xanthine derivatives. 8-Chlorotheophylline does not produce useful color reactions with Marquis, Mecke, or Mandelin reagents. Identification is irrelevant for harm reduction purposes.
Interactions
| Substance | Status | Note |
|---|---|---|
| Atropa belladonna | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Datura | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Diphenhydramine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Harmala alkaloid | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| MAOI | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| Myristicin | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Peganum harmala | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| 1,3-Butanediol | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1,4-Butanediol | Caution | Masks the effects of each drug; risk of overdosing when one wears off before the other |
| 1B-LSD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1cP-AL-LAD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1cP-LSD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
History
8-Chlorotheophylline is part of the stimulant class of psychoactive substances, which has a long and complex history spanning medical, military, occupational, and recreational use.
The modern history of stimulants begins with the isolation of ephedrine from traditional Chinese medicine in the 1880s, followed by the synthesis of amphetamine in 1887 and methamphetamine in 1893. Throughout the 20th century, stimulants were widely prescribed for conditions ranging from nasal congestion to depression, and were extensively used by militaries during World War II and the Korean War.
The recognition of abuse potential and adverse health effects led to increasing regulation from the 1960s onward, though stimulant medications remain among the most commonly prescribed treatments for ADHD and narcolepsy.
8-Chlorotheophylline exists within this broader context of stimulant pharmacology, with its specific history shaped by its date of development, clinical applications (if any), legal status, and pattern of use within different communities.
Harm Reduction
General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual sensitivity varies enormously.
- Test your substances: Use reagent test kits to verify identity and check for dangerous adulterants. Consider using drug checking services where available.
- Research thoroughly: Understand expected dose ranges, duration, potential interactions, and contraindications before use.
- Never use alone: Have a trusted, sober person present, especially with new substances or higher doses.
- Set and setting: Your mindset and environment profoundly influence the experience. Choose a safe, comfortable environment and ensure you're in a stable psychological state.
8-Chlorotheophylline-Specific Harm Reduction
- Cardiovascular monitoring: Stimulants increase heart rate and blood pressure. Avoid strenuous physical activity and stay hydrated. Those with heart conditions should not use stimulants.
- Hydration and nutrition: Eat before and during use, even if appetite is suppressed. Set reminders to drink water regularly but avoid overhydration.
- Sleep: Do not redose to avoid the comedown. Set a firm cutoff time to allow adequate sleep. Sleep deprivation amplifies negative effects and health risks.
- Compulsive redosing: Many stimulants produce a strong urge to redose. Pre-measure your dose and commit to it. Remove access to additional substance if possible.
- Dental health: Bruxism (jaw clenching) can damage teeth. Use magnesium supplements and consider a mouth guard for longer sessions.
- Combination danger: Never combine with MAOIs — this can cause hypertensive crisis. Combining with other stimulants compounds cardiovascular risk.
Toxicity & Safety
8-Chlorotheophylline carries significant toxicity risks, particularly with chronic use or high doses. Stimulant toxicity primarily affects the cardiovascular and nervous systems.
Cardiovascular toxicity: Stimulants increase heart rate, blood pressure, and cardiac workload. This can precipitate arrhythmias, myocardial infarction, aortic dissection, or stroke, particularly in individuals with pre-existing cardiovascular conditions or at very high doses.
Neurotoxicity: Chronic stimulant use can damage dopaminergic and serotonergic neurons. The extent of neurotoxicity depends on the specific compound, dose, frequency, and route of administration. Some stimulant-induced neurotoxic changes may be partially reversible with prolonged abstinence.
Psychiatric effects: High-dose or chronic stimulant use is associated with stimulant psychosis (paranoia, hallucinations), anxiety disorders, and depression during withdrawal. Sleep deprivation from stimulant use compounds these psychiatric risks.
Dependence potential: 8-Chlorotheophylline carries meaningful addiction potential due to dopaminergic reward pathway activation. Tolerance develops to euphoric effects, often leading to dose escalation. Withdrawal primarily involves fatigue, depression, anhedonia, and hypersomnia.
Other risks: Bruxism and dental damage, weight loss and malnutrition from appetite suppression, hyperthermia (especially with physical activity), and route-specific damage (nasal septum from insufflation, injection site infections).
It is strongly recommended that one use harm reduction practices when using this substance.
Overdose Information
Stimulant overdose from 8-Chlorotheophylline is a medical emergency primarily involving cardiovascular and neurological toxicity.
Signs of overdose: Extremely rapid or irregular heartbeat, chest pain, severe headache, dangerously elevated body temperature, seizures, agitation progressing to psychosis, confusion, and loss of consciousness.
Emergency response:
- Call emergency services immediately
- Keep the person cool (remove excess clothing, apply cool water)
- If seizures occur, protect the head and clear the area of hard objects
- If the person loses consciousness, place in recovery position
- Do not give the person more stimulants, caffeine, or depressants unless directed by medical professionals
Prevention: Pre-measure doses. Avoid redosing. Stay hydrated (but don't overhydrate). Take breaks from physical activity. Monitor heart rate if possible. Have someone present who can recognize warning signs.
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Tolerance
| Full | Develops with daily use over 1 - 2 weeks |
| Half | 1 - 3 days |
| Zero | 3 - 7 days |
Cross-tolerances
Legal Status
The legal status of 8-Chlorotheophylline varies by jurisdiction and is subject to change. This information is provided for educational purposes and may not reflect the most current legislation.
General patterns: Many psychoactive substances are controlled under national and international drug control frameworks, including the United Nations Single Convention on Narcotic Drugs (1961), the Convention on Psychotropic Substances (1971), and country-specific legislation such as the US Controlled Substances Act, UK Misuse of Drugs Act, and EU Framework Decisions.
Research chemicals and analogues: Novel psychoactive substances may be captured by analogue laws (e.g., the US Federal Analogue Act) or blanket bans on substance classes (e.g., the UK Psychoactive Substances Act 2016), even if the specific compound is not individually scheduled.
Important note: Possessing, distributing, or manufacturing controlled substances carries serious legal consequences in most jurisdictions. Legal status is not a reliable indicator of a substance's safety profile — some highly dangerous substances are legal, while some with favorable safety profiles are strictly controlled.
Users are strongly encouraged to research the specific legal status of 8-Chlorotheophylline in their jurisdiction before any involvement with this substance.
Tips (3)
Do not combine 8-Chlorotheophylline with MAOIs or other serotonergic drugs. Many stimulants have serotonergic activity, and combinations can cause serotonin syndrome or hypertensive crisis, both medical emergencies.
Eat a substantial meal before taking 8-Chlorotheophylline. Stimulants suppress appetite heavily, and going many hours without food leads to worse crashes, irritability, and cognitive impairment. Set phone reminders to eat and drink.
Weigh your dose of 8-Chlorotheophylline with a milligram scale. Street stimulants vary wildly in purity and potency. What looks like a normal amount could be significantly stronger than expected, especially with a new batch.
See Also
References (4)
- Amphetamine: new content for an old topic — Heal et al. Neuropsychopharmacology Reviews (2013)paper
- PubChem: 8-Chlorotheophylline
PubChem compound page for 8-Chlorotheophylline (CID: 10661)
pubchem - 8-Chlorotheophylline - TripSit Factsheet
TripSit factsheet for 8-Chlorotheophylline
tripsit - 8-Chlorotheophylline - Wikipedia
Wikipedia article on 8-Chlorotheophylline
wikipedia